Kairos Pharma, Ltd.
USD0.37
+0.02 (+4.76%)
CEO
John S. Yu
IPO Date
2024-09-16
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$0.35
Prev. Close
$0.36
Day Low
$0.35
Day High
$0.38
52W Low
$0.33
52W High
$2.11
Market Cap
$0.01B
Volume
0.01M
| 10,000 |
| $0.00 |
| 23 Dec 2025 | Bae Hyun W. | director | A-Award | Acquired | 19,084 | $0.00 |
| 26 Nov 2025 | Murali Ramachandran | VP of Research and Development | A-Award | Acquired | 152,672 | $0.00 |
| 26 Nov 2025 | Keyoung Hansoo Michael | director | A-Award | Acquired | 10,000 | $0.00 |
| 26 Nov 2025 | Keyoung Hansoo Michael | director | A-Award | Acquired | 19,084 | $0.00 |
| 26 Nov 2025 | Singhvi Rahul | director | A-Award | Acquired | 19,084 | $0.00 |
| 26 Nov 2025 | Samuelson Doug | Chief Financial Officer | A-Award | Acquired | 152,672 | $0.00 |
| 26 Nov 2025 | Yu John S | director, 10 percent owner, officer: CEO and Chairman | A-Award | Acquired | 190,840 | $0.00 |
| 30 Apr 2025 | Singhvi Rahul | director | Disposed | 0 | $0.00 |